carbachol has been researched along with Angiogenesis, Pathologic in 6 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Immunoglobulin G (IgG) from breast cancer patients in T1N0Mx stage (tumor size≤2 cm, without lymph node metastasis) mimics the action of the muscarinic agonist carbachol stimulating MCF-7 cell proliferation, migration and invasion." | 1.39 | Autoantibodies against muscarinic receptors in breast cancer: their role in tumor angiogenesis. ( Azar, ME; Castro, ME; Fiszman, GL; Lombardi, MG; Morgado, CC; Negroni, MP; Pelegrina, LT; Sales, ME, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Salem, AR | 1 |
| Martínez Pulido, P | 1 |
| Sanchez, F | 1 |
| Sanchez, Y | 2 |
| Español, AJ | 3 |
| Sales, ME | 5 |
| Salem, A | 1 |
| Di Bari, M | 1 |
| Cristofaro, I | 1 |
| Tata, AM | 1 |
| Lombardi, MG | 1 |
| Negroni, MP | 1 |
| Pelegrina, LT | 1 |
| Castro, ME | 1 |
| Fiszman, GL | 2 |
| Azar, ME | 1 |
| Morgado, CC | 1 |
| Brouet, A | 1 |
| DeWever, J | 1 |
| Martinive, P | 1 |
| Havaux, X | 1 |
| Bouzin, C | 1 |
| Sonveaux, P | 1 |
| Feron, O | 1 |
| Fiszman, G | 1 |
| Cattaneo, V | 1 |
| de la Torre, E | 2 |
| Español, A | 1 |
| Colombo, L | 1 |
| Sacerdote de Lustig, E | 1 |
| Middonno, MC | 1 |
| Farina, M | 1 |
6 other studies available for carbachol and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Effect of low dose metronomic therapy on MCF-7 tumor cells growth and angiogenesis. Role of muscarinic acetylcholine receptors.
Topics: Administration, Metronomic; Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transpo | 2020 |
The metronomic combination of paclitaxel with cholinergic agonists inhibits triple negative breast tumor progression. Participation of M2 receptor subtype.
Topics: Administration, Metronomic; Animals; Antineoplastic Combined Chemotherapy Protocols; Arecoline; ATP | 2020 |
Autoantibodies against muscarinic receptors in breast cancer: their role in tumor angiogenesis.
Topics: Animals; Antibodies, Neoplasm; Autoantibodies; Breast Neoplasms; Carbachol; Female; Fibroadenoma; Hu | 2013 |
Antitumor effects of in vivo caveolin gene delivery are associated with the inhibition of the proangiogenic and vasodilatory effects of nitric oxide.
Topics: Animals; Carbachol; Cell Movement; Drug Interactions; Endothelial Cells; Gene Expression; Genetic Th | 2005 |
Muscarinic receptors autoantibodies purified from mammary adenocarcinoma-bearing mice sera stimulate tumor progression.
Topics: Adenocarcinoma; Animals; Atropine; Autoantibodies; Blotting, Western; Carbachol; Cell Line, Tumor; C | 2006 |
Activation of muscarinic cholinergic receptors induces MCF-7 cells proliferation and angiogenesis by stimulating nitric oxide synthase activity.
Topics: Breast Neoplasms; Carbachol; Cell Line, Tumor; Cell Proliferation; Humans; Neovascularization, Patho | 2007 |